RVMDWRevolution Medicines Inc. Warrant

11.80USD-3.83%Mkt Cap: P/E:

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that bind…

Key Statistics

Company
Market Cap
Enterprise Value
Revenue (TTM)
Gross Profit-1.30B $
Net Income (TTM)-1.13B $
Revenue/Share
Last Price11.80 USD
Fiscal Year End
MR Quarter
Employees883
CountryUS
SectorFinancial Services
Industry
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA
EV/Revenue
P/S
P/B1.01
EPS (TTM)
EPS (Forward)
52W Range
1.79093% of range12.53
52W High12.53 USD
52W Low1.790 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-69.35%
ROA-48.05%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-897.74M $
CapEx (TTM)15.99M $
FCF Margin
FCF Yield
Net Debt-2.75B $
Net Debt/EBITDA1.70
Balance Sheet
Debt/Equity0.10
Current Ratio11.38
Quick Ratio11.12
Book Value/Sh12.16 USD
Cash/Share18.37 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.
Float184.45M
Insiders
Institutions
Technical
SMA 50
SMA 200
Beta1.40
S&P 52W Chg18.16%
Avg Vol (30d)6.20K
Avg Vol (10d)
Technical Indicators
RSI (14)83.9
MACD2.5345
MACD Signal1.7625
MACD Hist.+0.7720
BB Upper14.19 USD
BB Middle5.590 USD
BB Lower-3.0067 USD
BB Width307.58%
ATR (14)0.7954 USD
Vol Ratio (20d)0.72x